Vaccines

Andrew Lees lightheartedly states that he has built his career on two tenets: multivalency and being lazy. And it’s worked out well; while moonlighting as a magician, he has developed the conjugation chemistry behind some of the world's most-used vaccines. Here, he explains how he learned to combine science and magic.

In this white paper the specific mechanisms by which nanoparticles are designed and formulated for therapeutic purposes and in which NTA has had a significant part to play is discussed.

What if biologics and vaccines could be delivered via the buccal or sublingual route?

The 2015 Nobel Prize in Physiology or Medicine praises advances in parasitic tropical diseases.

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.

DNA vaccine helps turn patients’ own cells into antibody-producing factories.

After 28 years of R&D at GSK, the world has its first malaria vaccine.

Could existing drugs be repurposed as a shortcut to treating Ebola?

What impact will genetic changes have on new medicines currently in development?

With only one approved drug and many failures, the cancer vaccine field has lost some of its shine.